Heartbeam Inc

NASDAQ BEAT

Data sourced from iex and EODHD
Download Data

Heartbeam Inc Price to Earnings Ratio (P/E) on June 03, 2024: -22.96

Heartbeam Inc Price to Earnings Ratio (P/E) is -22.96 on June 03, 2024, a -1,596.96% change year over year. The price to earnings ratio (P/E ratio) compares the market price per share of a company's stock to its earnings per share (EPS). It is calculated by dividing the market capitalization by the net income, divided by the number of outstanding shares. This ratio provides insights into the market's valuation of a company's earnings. A higher P/E ratio indicates that investors are willing to pay a higher price for each unit of earnings, suggesting higher market expectations for future earnings growth.
  • Heartbeam Inc 52-week high Price to Earnings Ratio (P/E) is -1.25 on June 22, 2023, which is 94.54% above the current Price to Earnings Ratio (P/E).
  • Heartbeam Inc 52-week low Price to Earnings Ratio (P/E) is -24.54 on May 28, 2024, which is -6.91% below the current Price to Earnings Ratio (P/E).
  • Heartbeam Inc average Price to Earnings Ratio (P/E) for the last 52 weeks is -5.05.
NASDAQ: BEAT

Heartbeam Inc

CEO Mr. Richard M. Ferrari
IPO Date Nov. 11, 2021
Location United States
Headquarters 2118 Walsh Avenue, Santa Clara, CA, United States, 95050
Employees 15
Sector Healthcare
Industry Health information services
Description

HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.

StockViz Staff

September 8, 2024

Any question? Send us an email